Recently, polymorphisms such as ARID5B have been associated with a higher incidence of ALL and greater risk of relapse in Hispanic patients, a finding that may explain the higher incidence and worse results in Hispanic patients [45, 46]. The gene discussed is ARID5B; the disease is acute lymphoblastic leukemia.